Computational analysis of flow cytometry data in hematological malignancies: future clinical practice?

Area of Science:

• Hematology
• Computational Biology
• Data Science

Background:

• Clinical flow cytometry is crucial for diagnosing hematological malignancies.
• Manual analysis can be subjective and time-consuming.
• Advancements in computational methods offer potential improvements.

Purpose of the Study:

• To review recent advancements in computational analysis of clinical flow cytometry data for hematological malignancies.
• To highlight the impact of these methods on diagnosis, classification, and treatment monitoring.

Main Methods:

• Integration of dimension reduction techniques (e.g., PCA) and clustering algorithms (e.g., FlowSOM).
• Application of machine learning classifiers (e.g., SVM, Random Forest).
• Analysis of flow cytometry data for various hematological malignancies.

Main Results:

• High concordance with expert manual analysis for B-cell chronic lymphoid leukemia and acute leukemia.
• Improved diagnostic accuracy for myelodysplastic syndromes and lymphoma.
• Promising results in minimal residual disease detection and treatment response monitoring, though relapse prediction remains challenging.

Conclusions:

• Computational analysis enhances ease of use, objectivity, and accuracy in clinical flow cytometry for hematological malignancies.
• Multicenter collaboration and prospective validation are essential for clinical implementation.
• These methods hold significant potential for improving patient care and outcomes.